Sectra ABMIL:1SECT 76 3-Year RORE % is 12.28 as of Apr. 2026. GuruFocus rates MIL:1SECT with a GF Score™ of 76/100 and a GF Value™ of €28.93 (Fairly Valued). Among 782 Medical Devices & Instruments companies, Sectra AB ranks better than 69.95% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Sectra AB's 3-Year RORE % for the quarter that ended in Apr. 2026 was 12.28%.
The industry rank for Sectra AB's 3-Year RORE % or its related term are showing as below:
MIL:1SECT's 3-Year RORE % is ranked better than 69.95% of 782
companies
in the Medical Devices & Instruments industry
Industry Median: -4.17
vs MIL:1SECT: 12.28
Sectra AB (MIL:1SECT) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Sectra AB 3-Year RORE % Related Terms
Sectra AB 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Sectra AB's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1SECT vs ABT, SYK, MDT: 3-Year RORE % Comparison
For the Medical Devices subindustry, Sectra AB's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB 3-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Sectra AB's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Apr. 2026 and 3-year before.
Sectra AB (MIL:1SECT) has a 3-Year RORE % of 12.28 as of Apr. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Sectra AB and its competitors. According to the industry distribution chart, Sectra AB ranks #235 out of 782 companies in the Medical Devices & Instruments industry, placing it in the top 30.1%.
Is Sectra AB's 3-Year RORE % too high?
Sectra AB's current 3-Year RORE % is 12.28. Based on the distribution chart, Sectra AB ranks #235 out of 782 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sectra AB has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's 3-Year RORE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #235 out of 782 companies for 3-Year RORE %. This puts Sectra AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Sectra AB and its competitors. Sectra AB's current 3-Year RORE % is 12.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (MIL:1SECT) is currently considered Fairly Valued. The stock's GF Value™ is €28.93, compared to a current price of €27.38 — trading 5.4% below its estimated fair value. The current 3-Year RORE % is 12.28. Sectra AB's overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Sectra AB (MIL:1SECT), the current 3-Year RORE % is 12.28 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (MIL:1SECT) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of €27.38 is trading 5.4% below its estimated GF Value™ of €28.93.
GuruFocus considers Sectra AB to be Fairly Valued.
Key valuation signals for MIL:1SECT:
3-Year RORE %: 12.28
GF Value™: €28.93 vs. price of €27.38 (5.4% below fair value)
No single metric tells the full story. See the MIL:1SECT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
76GF Score
Get the complete analysis for MIL:1SECT
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1SECT has been successfully added to your 
